Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation:: Results of the experience with left ventricular assist device with exercise trial

被引:51
|
作者
Jaski, BE [1 ]
Lingle, RJ [1 ]
Kim, J [1 ]
Branch, KR [1 ]
Goldsmith, R [1 ]
Johnson, MR [1 ]
Lahpor, JR [1 ]
Icenogle, TB [1 ]
Piña, I [1 ]
Adamson, R [1 ]
Favrot, LK [1 ]
Dembitsky, WP [1 ]
机构
[1] San Diego Cardiac Ctr, San Diego, CA 92123 USA
来源
关键词
D O I
10.1016/S1053-2498(99)00071-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Use of a permanent left ventricular assist device (LVAD) has been proposed as an alternate treatment of patients with end-stage heart failure. The purpose of this study was to compare the functional capacity of patients following implantation of a LVAD vs heart transplant (HTx). Methods: Eighteen patients from 6 centers who received an intracorporeal LVAD as a bridge to HTx underwent treadmill testing 1 to 3 months post-LVAD and again post-HTx. Baseline and peak measurements, including oxygen consumption, blood pressures, and respiratory rate were made during each treadmill test. Results: Peak oxygen consumption was 14.5 +/- 3.9 ml/kg/minute post-LVAD and 175 +/- 5.0 ml/kg/minute post-HTx (p < .005). The percentage of the predicted peak oxygen consumption based on gender, weight, and age was 39.5% +/- 5.5% post-LVAD and 47.7% +/- 10.9% post-HTx (p < .005). Exercise duration was lower post-LVAD than post-HTx (10.3 +/- 4.2 minute vs 12.5 +/- 5.4 minute, p < .05). After LVAD implantation, peak total oxygen consumption correlated with peak LVAD rate and output. Eight patients reached an LVAD rate of 120 beats per minute (bpm) before the conclusion of exercise, the maximum rate for the outpatient electric device. The peak respiratory exchange ratio post-LVAD was 1.15 +/- 0.22 and post-HTx was 1.15 +/- 0.18, consistent with a good effort in both groups. Conclusions: Patients demonstrated a lower functional capacity post-LVAD than post-HTx. For some patients functional capacity post-LVAD may be improved by a higher maximum LVAD rate and output.
引用
收藏
页码:1031 / 1040
页数:10
相关论文
共 50 条
  • [21] Outcomes of Heart Transplantation versus Left Ventricular Assist Device Implantation in Septuagenarians
    Lin, A.
    Begur, M.
    John, S.
    Dharmavaram, G.
    Gernhofer, Y.
    Ignatyeva, Y.
    Kearns, M.
    Adler, E.
    Pretorius, V.
    Tran, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S206 - S206
  • [22] Cost Comparison between Heart Transplantation and Left Ventricular Assist Device Implantation
    Kilic, Ahmet
    Phillips, Gary
    Chimanji, Neeraj
    Sai-Sudhakar, Chittoor B.
    Hasan, Ayesha
    Higgins, Robert S. D.
    Whitson, Bryan A.
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S84 - S84
  • [23] Left ventricular assist device implantation On track to becoming the new gold standard for patients with end-stage heart failure
    Krabatsch, Thomas
    Potapov, E.
    Knosalla, C.
    Falk, Volkmar
    EUROPEAN HEART JOURNAL, 2016, 37 (23) : 1785 - 1786
  • [24] Sympathetic vasoconstrictor activity before and after left ventricular assist device implantation in patients with end-stage heart failure
    Heusser, Karsten
    Wittkoepper, Judith
    Bara, Christoph
    Haverich, Axel
    Diedrich, Andre
    Levine, Benjamin D.
    Schmitto, Jan D.
    Jordan, Jens
    Tank, Jens
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (11) : 1955 - 1959
  • [25] Comparison of Early Versus Delayed Left Ventricular Assist Device Implantation in Patients Bridged to Heart Transplantation
    Kitada, S.
    Schulze, P.
    Jin, Z.
    Clerkin, K.
    Homma, S.
    Mancini, D. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S56 - S56
  • [26] Caring for a spouse with end-stage heart failure through implantation of a left ventricular assist device as destination therapy
    Kitko, Lisa A.
    Hupcey, Judith E.
    Gilchrist, Juliann H.
    Boehmer, John P.
    HEART & LUNG, 2013, 42 (03): : 195 - 201
  • [27] Caring for a spouse with end-stage heart failure through implantation of a left ventricular assist device as a destination therapy
    Alkhuja, Samer
    Gazizov, Natalya
    Alexander, Mary Ellen
    HEART & LUNG, 2013, 42 (05): : 389 - 390
  • [28] Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure?
    Prescimone, T.
    Caruso, R.
    Campolo, J.
    Caselli, C.
    Cabiati, M.
    Boroni, C.
    Del Ry, S.
    Parodi, O.
    Giannessi, D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 81 - 81
  • [29] TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device
    Bruggink, A. H.
    van Oosterhout, M. F. M.
    De Jonge, N.
    Gmelig-Meyling, F. H. J.
    De Weger, R. A.
    TRANSPLANT IMMUNOLOGY, 2008, 19 (01) : 64 - 68
  • [30] LEFT VENTRICULAR ASSIST DEVICE DOES NOT IMPROVE CELLULAR IMMUNITY IN END-STAGE HEART FAILURE
    Lundgren, Scott
    Lyden, Elizabeth
    Burdorf, Adam
    Hyden, Marshall
    Stoller, Douglas
    Zolty, Ronald
    Um, John
    Lowes, Brian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 950 - 950